Member Comments are provided by individuals and reflect their personal opinions only. Under NO circumstances should you act on any advice or opinion posted in this forum.  ALWAYS check with your personal physician before taking any action regarding your health! MedHelp International and our partners, sponsors and affiliates have no obligation to monitor any comments posted on this site, or the content and/or accuracy of such exchanges. MedHelp International does not endorse the views of any user.
Chemotherapy  (Expert Forum)
 | 
Recurrent ovarian cancer treatment
Answered by
Bangalore Institute of Oncology Bangalore - India
Welcome to the International Chemotherapy forum. Questions related to lung cancer will be answered by a medical doctor.

Recurrent ovarian cancer treatment

by bohan54, Mar 22, 2009 07:54PM
Hello,
My dx was stage 3c in 6/2008.  I was a participant in the GOG trial using standard chemo plus either Avastin or a placebo however my cancer recurred almost immediately upon completion of the 6 treatments of Carbo/Taxol.  My oncologist is now recommending Topotecan for my next round, 3 weeks on 1 week off.  My question is why is one drug suggested over another ie. why not Doxil or Gemzar?  Also, are there any statistics showing the rate of success of Topo for second line therapy?
Thanks,
Sharon
  

by Kamal S Saini, MD, MRCP (UK), DM, Mar 23, 2009 06:28AM
To: bohan54
Hi,
I assume that you got the chemo for the commoner epithelial type of ovarian cancer. What surgery was performed? What were the Ca 125 levels before and after chemotherapy? Did the cancer disappear completely before re-appearing?
Your cancer is platinum resistant, as it came back shortly after completing platinum based treatment.
According to the NCCN (National Comprehensive Cancer Network) 2009 guidelines, acceptable chemotherapy drugs in relapsed (platinum resistant) ovarian cancer include liopsomal doxorubicin, docetaxel, gemcitabine, etoposide, paclitaxel (weekly), pemetrexed, and topotecan.
There is no overwhelming data to support the selection of one drug over the others, and doctor and patient preference plays a large part in deciding which agent to choose. In phase III clinical trials, topotecan proved to be equivalent in efficacy to both paclitaxel and liposomal doxorubicin as second-line therapy in patients with relapsed ovarian cancer.
Alternatively, you may decide to enrole in another clinical trial.
All the best, and God Bless!
Member Comments (3)

by bohan54, Mar 23, 2009 06:51AM
To: Dr. Saini
I had a total hysterectomy with optimal debulking.  Highest CA 125 was 2900, it went to 28 after 6 rounds of Carbo/Taxol.  There was a 7mm spot leftover which when grew to 9mm in 2 months.  Biopsy done on 3/6/09 confirmed  malignancy.  
Thank you for your prompt reply to my question.   Will give the Topotecan a try and hope for stability.
Sharon

by Kamal S Saini, MD, MRCP (UK), DM, Mar 23, 2009 07:49PM
To: bohan54
Hi Sharon, I wish you good luck!
Continue discussion
RSS Expert Activity
When Your Cold Is Not A Cold
10 hrs ago by Steven Y Park, MD
Cataract, Removal, Artificial Lens,...
Dec 08 by Jim Humphries, B.S., D.V.M.
7 Ways to Reduce Stress During the ...
Dec 07 by Steven Y Park, MD